Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
158.85
+2.85 (1.82%)
Nov 21, 2024, 2:04 PM EST - Market open
Biogen Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,615 | 1,161 | 3,047 | 1,556 | 4,001 | 5,889 | Upgrade
|
| Depreciation & Amortization | 629.3 | 494.8 | 518.4 | 487.7 | 457.2 | 464.7 | Upgrade
|
| Loss (Gain) From Sale of Assets | -88.6 | - | -503.7 | - | -92.5 | 55.3 | Upgrade
|
| Asset Writedown & Restructuring Costs | 20.2 | - | 119.6 | 647.3 | 284.7 | 215.9 | Upgrade
|
| Loss (Gain) From Sale of Investments | 24.1 | 277.1 | -1,240 | 826.8 | -681.8 | -147.3 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | -2.6 | -34.9 | -3.3 | 77.4 | Upgrade
|
| Stock-Based Compensation | 271 | 264.2 | 254.1 | 238.6 | 198.3 | 182.3 | Upgrade
|
| Other Operating Activities | 487.5 | -1.3 | 81.4 | 63.8 | 253.8 | 142.5 | Upgrade
|
| Change in Accounts Receivable | 265.4 | 61.3 | -203.4 | 324.8 | 2.8 | 68.8 | Upgrade
|
| Change in Inventory | -303.4 | -130.9 | -320.2 | -462.4 | -316.3 | -19.2 | Upgrade
|
| Change in Other Net Operating Assets | -671.5 | -280.1 | -224.4 | -238.7 | 193.8 | 133.6 | Upgrade
|
| Operating Cash Flow | 2,127 | 1,547 | 1,384 | 3,640 | 4,230 | 7,079 | Upgrade
|
| Operating Cash Flow Growth | 56.44% | 11.77% | -61.97% | -13.95% | -40.25% | 14.40% | Upgrade
|
| Capital Expenditures | -179.6 | -277 | -240.3 | -258.1 | -424.8 | -514.5 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 582.6 | - | - | - | Upgrade
|
| Cash Acquisitions | -1,665 | -6,926 | - | - | -141.8 | -1,044 | Upgrade
|
| Divestitures | - | - | - | 28.1 | - | 923.7 | Upgrade
|
| Sale (Purchase) of Intangibles | -179.1 | -34.4 | -2.9 | -36.8 | -127 | -155 | Upgrade
|
| Investment in Securities | 516.9 | 3,148 | 1,213 | -309.8 | 111.9 | 1,234 | Upgrade
|
| Other Investing Activities | 74.2 | -11.3 | 24.4 | 12.9 | -26.9 | 27 | Upgrade
|
| Investing Cash Flow | -1,433 | -4,101 | 1,577 | -563.7 | -608.6 | 470.5 | Upgrade
|
| Long-Term Debt Issued | - | 997.2 | - | - | 2,967 | - | Upgrade
|
| Long-Term Debt Repaid | - | -809.9 | -1,002 | -170 | -1,500 | - | Upgrade
|
| Net Debt Issued (Repaid) | -1,300 | 187.3 | -1,002 | -170 | 1,467 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -750 | -1,800 | -6,679 | -5,868 | Upgrade
|
| Other Financing Activities | -37.5 | -38 | 4.9 | -116.2 | -61 | 7.9 | Upgrade
|
| Financing Cash Flow | -1,338 | 149.3 | -1,747 | -2,086 | -5,273 | -5,860 | Upgrade
|
| Foreign Exchange Rate Adjustments | 54.6 | 35.1 | -55.7 | -59.8 | 69 | 0.4 | Upgrade
|
| Net Cash Flow | -588.7 | -2,369 | 1,158 | 930.2 | -1,583 | 1,689 | Upgrade
|
| Free Cash Flow | 1,948 | 1,270 | 1,144 | 3,382 | 3,805 | 6,564 | Upgrade
|
| Free Cash Flow Growth | 83.47% | 11.03% | -66.17% | -11.12% | -42.03% | 21.17% | Upgrade
|
| Free Cash Flow Margin | 20.27% | 12.91% | 11.25% | 30.79% | 28.30% | 45.65% | Upgrade
|
| Free Cash Flow Per Share | 13.34 | 8.72 | 7.84 | 22.61 | 23.59 | 35.03 | Upgrade
|
| Cash Interest Paid | 252.2 | 252.2 | 262.5 | 280.8 | 272.7 | 244.2 | Upgrade
|
| Cash Income Tax Paid | 740.7 | 740.7 | 932.9 | 247.9 | 906.7 | 1,065 | Upgrade
|
| Levered Free Cash Flow | 2,031 | 971.06 | 1,393 | 2,208 | 2,878 | 4,638 | Upgrade
|
| Unlevered Free Cash Flow | 2,194 | 1,125 | 1,547 | 2,365 | 3,011 | 4,755 | Upgrade
|
| Change in Net Working Capital | -189.5 | 892.6 | 878.8 | 226 | 6.5 | -196.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.